Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether Biosenta is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Biosenta has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Biosenta. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Biosenta's earnings available for a low price, and how does
this compare to other companies in the same industry?
Biosenta has negative assets, we can't compare the value of its assets to the North America Household Products industry average.
When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Biosenta's regulatory filings and announcements.
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biosenta has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Household Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Biosenta's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Biosenta's earnings growth to the Canada market average as no estimate data is available.
Unable to compare Biosenta's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if Biosenta is high growth as no earnings estimate data is available.
Unable to determine if Biosenta is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Biosenta's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Amarvir Gill, also known as Am, has been President and Chief Executive Officer at Biosenta Inc., since July 16, 2019 and its Director since November 1, 2016 and serves as its Interim Chief Financial Officer. Mr. Gill has eighteen years of experience in Money and Capital Markets with major banks and energy companies, where he held roles as Treasurer and has been delegated signing officer for these companies.
Insufficient data for Am to compare compensation growth.
Insufficient data for Am to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Board of Directors Tenure
Average tenure of the
board of directors in years:
The tenure for the Biosenta board of directors is about average.
Board of Directors
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
What Investors Should Know About Biosenta Inc.'s (CNSX:ZRO) Financial Strength
Want to participate in a short research study? … Help shape the future of investing tools and you could win a $250 gift card! … (CNSX:ZRO) with its market cap of CA$984k, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.
Could Biosenta Inc's (CNSX:ZRO) Investor Composition Influence The Stock Price?
The big shareholder groups in Biosenta Inc (CNSX:ZRO) have power over the company. … As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.'. … With a market capitalization of CA$703k, Biosenta is a small cap stock, so it might not be well known by many institutional investors.
Should You Be Concerned About Biosenta Inc's (CNSX:ZRO) Shareholders?
I am going to take a deep dive into Biosenta Inc’s (CNSX:ZRO) most recent ownership structure, not a frequent subject of discussion among individual investors. … Ownership structure has been found to have an impact on shareholder returns in both short- and long-term. … The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment.
Biosenta Inc. develops and deploys anti-microbial products and remediation solutions for commercial and consumer applications in Canada. The company offers disinfectants and cleaners to kill mold, fungi, bacteria, and viruses on contact and prevent re-growth under the ZeroMold and True brand names. It also intends to manufacture and distribute Tri-filler, an anti-microbial filler to perform filling and bulking functions, as well as offers Eco-Brite, a multi-purpose bio safe cleanser. In addition, the company engages in the development of Purity, a hospital-grade disinfectant. It serves retail, institutional, and industrial users. Biosenta Inc. is based in Toronto, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.